0001652130EX-FILING FEESfalse 0001652130 2025-06-11 2025-06-11 0001652130 1 2025-06-11 2025-06-11 iso4217:USD xbrli:pure
Exhibit 107.1
CALCULATION OF REGISTRATION FEE
Form
S-8
(Form Type)
Intellia Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
Newly Registered Securities
 
               
Security Type  
Security
Class
Title
 
Fee
Calculation
Rule
 
Amount
Registered (1)
 
Proposed
Maximum
Offering
Price Per
Share
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
               
Equity   Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan  
Rule
457(c)
and
Rule
457(h)
 
22,853,528
shares (2)
 
$7.60
(3)
  $173,686,812.80 (3)   $0.00015310   $26,591.46
         
Total Offering Amounts     $173,686,812.80     $26,591.46
         
Total Fees Previously Paid        
         
Total Fee Offsets        
         
Net Fee Due               $26,591.46
  (1)
In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock.
  (2)
Represents 22,853,528 shares of Intellia Therapeutics. Inc. Common Stock reserved for issuance under the Registrant’s 2025 Equity Incentive Plan.
  (3)
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of $7.60, the average of the high and low price of the Registrant’s Common Stock as reported on the NASDAQ Global Market on June 5, 2025.